Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
09 2021
Historique:
received: 06 01 2021
revised: 18 06 2021
accepted: 26 06 2021
pubmed: 11 7 2021
medline: 28 10 2021
entrez: 10 7 2021
Statut: ppublish

Résumé

Schizophrenia (SZ) and Autism Spectrum Disorder (ASD) show overlap in social cognitive and functioning impairments. Proposed predictors of social functioning (SF) and quality of life (QL) have been symptom severity, IQ and social cognition. Empathy has rarely been compared between ASD and SZ and its predictive power on functional outcomes is unclear. We investigated general, affective, and cognitive empathy in 46 SZ, 30 ASD and 51 healthy controls (HC) and examined their relationship to SF and QL in addition to IQ and symptoms. SZ and ASD shared deficits in general and cognitive empathy, and personal distress, but only SZ showed deficits in affective empathy. Both groups showed lower performance-based empathy scores and only ASD showed slower responses compared to HC. Negative symptoms predicted QL in both groups, the more negative symptoms the worse QL (ASD t=-3.22; SZ t= -3.43; p<0.01), and only in ASD, IQ predicted QL, the higher the IQ the higher QL (t = 2.1; p<0.05). In ASD only, negative symptoms predicted SF, the greater negative symptoms the worse SF (t=-3.45; p<0.01), and communication deficits predicted SF, the higher deficits, the higher SF (t = 2.9; p<0.01). Negative symptoms but not empathy were the shared predictors of functioning across ASD and SZ.

Identifiants

pubmed: 34246005
pii: S0165-1781(21)00384-X
doi: 10.1016/j.psychres.2021.114087
pmc: PMC8373814
mid: NIHMS1722497
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

114087

Subventions

Organisme : RRD VA
ID : IK6 RX002458
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH095888
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Clin Psychol Rev. 2014 Feb;34(1):73-86
pubmed: 24424351
Neuroimage Clin. 2020;27:102343
pubmed: 32711391
J Autism Dev Disord. 2004 Apr;34(2):163-75
pubmed: 15162935
Br J Psychiatry. 1990 Dec;157:853-9
pubmed: 2289094
Schizophr Bull. 2014 Jul;40(4):824-34
pubmed: 23770935
Psychiatry Res. 2012 Dec 30;200(2-3):102-7
pubmed: 22769048
Schizophr Res. 2008 Feb;99(1-3):164-75
pubmed: 18053686
Eur Psychiatry. 2014 Oct;29(8):463-72
pubmed: 24630376
Philos Trans R Soc Lond B Biol Sci. 2003 Feb 28;358(1430):361-74
pubmed: 12639333
Psychiatry Res. 2007 Jan 15;149(1-3):11-23
pubmed: 17107716
Schizophr Res. 2004 Dec 15;72(1):41-51
pubmed: 15531406
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
pubmed: 16916889
J Autism Dev Disord. 2010 Apr;40(4):416-23
pubmed: 19949846
J Autism Dev Disord. 2001 Feb;31(1):19-28
pubmed: 11439750
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Psychiatry Res. 2017 Mar;249:293-303
pubmed: 28142103
Schizophr Res. 2019 Aug;210:94-100
pubmed: 31178362
J Autism Dev Disord. 2008 Mar;38(3):464-73
pubmed: 17990089
Neurosci Biobehav Rev. 2006;30(6):855-63
pubmed: 16904182
ScientificWorldJournal. 2006 Sep 20;6:1146-63
pubmed: 16998603
Brain. 2009 Mar;132(Pt 3):617-27
pubmed: 18971202
Am J Psychiatry. 1996 Mar;153(3):321-30
pubmed: 8610818
Ann N Y Acad Sci. 2009 Jun;1167:174-81
pubmed: 19580563
Neuroimage. 2011 Jul 15;57(2):642-50
pubmed: 21549201
Am J Psychiatry. 2006 Mar;163(3):418-25
pubmed: 16513862
Autism Res. 2017 May;10(5):878-887
pubmed: 28112487
Schizophr Bull. 2000;26(1):119-36
pubmed: 10755673
Schizophr Res. 2019 Jun;208:153-159
pubmed: 31006615
J Psychiatr Res. 2016 Aug;79:21-27
pubmed: 27131617
PLoS One. 2018 Jul 27;13(7):e0198273
pubmed: 30052646
Soc Neurosci. 2007;2(3-4):254-75
pubmed: 18633818
J Autism Dev Disord. 2017 Oct;47(10):3007-3017
pubmed: 28710532
Schizophr Res. 2011 Feb;125(2-3):152-60
pubmed: 20965699
Psychol Med. 2010 Apr;40(4):569-79
pubmed: 19671209
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
PLoS One. 2007 Sep 12;2(9):e883
pubmed: 17849012
Schizophr Res. 2012 May;137(1-3):196-202
pubmed: 22321668
Psychol Med. 2004 Jul;34(5):911-9
pubmed: 15500311
Autism. 2017 Oct;21(7):896-906
pubmed: 27407040
Assessment. 2016 Dec;23(6):769-777
pubmed: 26253573
Psychiatry Res. 2014 Dec 30;220(3):825-33
pubmed: 25288043
Autism Res. 2019 Apr;12(4):645-657
pubmed: 30741482
Neuroimage Clin. 2019;24:101966
pubmed: 31401405
Psychiatry Res. 2008 Jul 15;160(1):23-9
pubmed: 18514324
J Pers Assess. 2011 Jan;93(1):84-95
pubmed: 21184334
World Psychiatry. 2019 Jun;18(2):146-161
pubmed: 31059632
Schizophr Bull. 2009 Jul;35(4):798-806
pubmed: 18308717
Front Psychiatry. 2020 Jun 11;11:548
pubmed: 32595540
Neurosci Biobehav Rev. 2011 Jan;35(3):573-88
pubmed: 20620163
Schizophr Res. 2013 Aug;148(1-3):24-8
pubmed: 23768814
J Autism Dev Disord. 2019 Oct;49(10):3939-3955
pubmed: 31147901
J Autism Dev Disord. 2011 Nov;41(11):1475-86
pubmed: 21347615
Psychiatry Res. 2014 Dec 30;220(3):803-10
pubmed: 25632418
Cogn Neuropsychiatry. 2014;19(3):205-25
pubmed: 23998722
Cogn Neuropsychiatry. 2006 Mar;11(2):133-55
pubmed: 16537239
Schizophr Bull. 1984;10(3):388-98
pubmed: 6474101
JAMA Psychiatry. 2021 Mar 1;78(3):281-292
pubmed: 33291141
Psychiatry Res. 2019 Jun;276:56-59
pubmed: 31015067
J Autism Dev Disord. 2009 Jul;39(7):1066-78
pubmed: 19234777
Schizophr Res. 2013 Feb;143(2-3):277-84
pubmed: 23266067
J Autism Dev Disord. 2011 Aug;41(8):1007-18
pubmed: 21042872
Acta Psychiatr Scand. 2016 Jun;133(6):445-52
pubmed: 26763353
Schizophr Bull. 2016 May;42(3):675-83
pubmed: 26645375
J Neurodev Disord. 2011 Jun;3(2):87-100
pubmed: 21484194
Mol Autism. 2017 May 22;8:21
pubmed: 28540026
Nat Rev Neurosci. 2015 Oct;16(10):620-31
pubmed: 26373471
Cogn Neuropsychiatry. 2015;20(2):157-71
pubmed: 25530230
Schizophr Res. 2015 Jun;165(1):76-82
pubmed: 25868935

Auteurs

Silvia Corbera (S)

Department of Psychological Science, Central Connecticut State University, New Britain, CT, United States; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT, United States. Electronic address: silviac@ccsu.edu.

Bruce E Wexler (BE)

Department of Psychiatry, Yale University, New Haven, CT, United States.

Morris D Bell (MD)

Department of Psychiatry, Yale University, New Haven, CT, United States; VA Connecticut Healthcare System, West Haven, CT, United States.

Godfrey Pearlson (G)

Department of Psychiatry, Yale University, New Haven, CT, United States; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT, United States.

Sophy Mayer (S)

Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT, United States.

Brian Pittman (B)

Department of Psychiatry, Yale University, New Haven, CT, United States.

Vaishali Belamkar (V)

Department of Psychological Science, Central Connecticut State University, New Britain, CT, United States.

Michal Assaf (M)

Department of Psychiatry, Yale University, New Haven, CT, United States; Olin Neuropsychiatry Research Center, Institute of Living, Hartford Hospital, Hartford, CT, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH